QINGHAOSU(QHS)-DERIVATIVE
Compound with spectra: 1 NMR
| SpectraBase Compound ID | 2Nm6dmiVvem |
|---|---|
| InChI | InChI=1S/C15H22O5/c1-7-4-5-9-8(2)12(16)18-13-15(9)10(7)6-11(19-15)14(3,17)20-13/h7-11,13,17H,4-6H2,1-3H3/t7-,8?,9+,10+,11-,13-,14?,15+/m1/s1 |
| InChIKey | MOXQWWWAYABRLP-HNBJJVKJSA-N |
| Mol Weight | 282.34 g/mol |
| Molecular Formula | C15H22O5 |
| Exact Mass | 282.146724 g/mol |
| Enantiomer InChIKey | MOXQWWWAYABRLP-RHSQLZMUSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | Unknown |
13-(1-NITROETHYL)-ARTEMISIN
#8;5-(METHOXYCARBONYL)-PENTYL-3,4-DI-O-BENZOYL-2-O-METHYL-ALPHA-L-FUCOPYRANOSYL-(1->2)-3,6-DI-O-BENZYL-4-O-METHYL-BETA-D-GALACTOPYRANOSYL-(1->3)-2-AZIDE-4,6-BE
17-tert-Butoxy-2,5-epoxy-2a-oxa-A-homoandrost-3-ene
9-BETA-HYDROXYARTEMISININ
9-BETA-HYDROXY-11-EPI-ARTEMISININ
13-METHOXYCARBONYL_1X
Clostebol, O,O'-bis-TBS
[3-[(7-CHLORO-QUINOLIN-4-YL)-AMINO]-PROPYL]-[2-[(10-BETA-DIHYDRO-ARTEMISININ-10-YL)-OXY]-ETHYL]-AMINE
2-Amino-4-(3-iodo-4,5-dimethoxyphenyl)-5-oxo-4,5-dihydro-pyrano[3,2-c]chromene-3-carbonitrile
(1Z)-7-Chloro-1-([(Z)-2-(diethylamino)propyl]imino)-10-hydroxy-3-[3-(trifluoromethyl)phenyl]-1,3,4,10-tetrahydro-9(2H)-acridinone
| Title | Journal or Book | Year |
|---|---|---|
| The Chemistry of Drugs. VI. Thermal Decomposition of Qinghaosu | HETEROCYCLES | 1985 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.
KnowItAll Mass Spectral Library
Author: Wiley
The KnowItAll Mass Spectral Library offers a comprehensive collection of mass spectra, including the renowned Wiley Registry, and access to a wide range of compounds including pure organics, drugs, steroids, additives, geochemicals, petrochemicals, biomarkers, and more. Learn more.